Bios Capital Management, LP In8 Bio, Inc. Transaction History
Bios Capital Management, LP
- $95.9 Billion
- Q4 2024
A detailed history of Bios Capital Management, LP transactions in In8 Bio, Inc. stock. As of the latest transaction made, Bios Capital Management, LP holds 8,600,001 shares of INAB stock, worth $2.24 Million. This represents 2.31% of its overall portfolio holdings.
Number of Shares
8,600,001Holding current value
$2.24 Million% of portfolio
2.31%Shares
1 transactions
Others Institutions Holding INAB
# of Institutions
29Shares Held
16.4MCall Options Held
0Put Options Held
0-
Aigh Capital Management LLC Baltimore, MD1.67MShares$435,4050.18% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.42MShares$370,2130.0% of portfolio
-
683 Capital Management, LLC New York, NY1.35MShares$351,0790.03% of portfolio
-
Sigma Planning Corp Ann Arbor, MI1.04MShares$270,7580.01% of portfolio
-
Ensign Peak Advisors, Inc Salt Lake City, UT829KShares$215,5850.0% of portfolio
About IN8BIO, INC.
- Ticker INAB
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 24,502,200
- Market Cap $6.37M
- Description
- IN8bio, Inc., a clinical-stage biotechnology company, focuses on the discovery, development, and commercialization of gamma-delta T cell therapies for the treatment of cancers. Its lead product candidate includes INB-200, a genetically modified autologous gamma-delta T cell product candidate that is in Phase I clinical trial for the treatment of...